Abstract
The F1FO-ATP synthase is the only enzyme in nature endowed with bi-functional catalytic mechanism of synthesis and hydrolysis of ATP. The enzyme functions, not only confined to energy transduction, are tied to three intrinsic features of the annular arrangement of c subunits which constitutes the so-called c-ring, the core of the membrane-embedded FO domain: (i) the c-ring constitution is linked to the number of ions (H+ or Na+) channeled across the membrane during the dissipation of the transmembrane electrochemical gradient, which in turn determines the species-specific bioenergetic cost of ATP, the “molecular currency unit” of energy transfer in all living beings; (ii) the c-ring is increasingly involved in the mitochondrial permeability transition, an event linked to cell death and to most mitochondrial dysfunctions; (iii) the c subunit species-specific amino acid sequence and susceptibility to post-translational modifications can address antibacterial drug design according to the model of enzyme inhibitors which target the c subunits. Therefore, the simple c-ring structure not only allows the F1FO-ATP synthase to perform the two opposite tasks of molecular machine of cell life and death, but it also amplifies the enzyme’s potential role as a drug target.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The membrane-bound ATP synthase or F1FO-ATPase (EC 3.6.3.14) has the primary role of synthesizing ATP, the molecular energy currency of living cells. Its catalytic ability coupled to a nearly ubiquitous occurrence makes it deserve the universal definition of enzyme of life (Junge and Müller 2011). Its prominent role in the bioenergetic machinery of the cell is equaled by a fascinating nano-molecular architecture which enables the F1FO complex to work as a frictionless engine (von Ballmoos et al. 2008), by a key molecular strategy, based on the so-called torque generation (Junge et al. 2009). Accordingly, the energy transfer within the enzyme complex is based on a torsional mechanism which matches the work of two distinct enzyme sectors of the F1FO-ATP synthase: the extrinsic sector or F1, which protrudes outside of the membrane and catalyzes the synthesis/hydrolysis of ATP, and the transmembrane sector or FO, which channels ions across the membrane (Walker 2013). The two opposite functions of ATP synthesis and hydrolysis are based on the capability of the membrane-embedded rotor to rotate in two directions. In the presence of transmembrane proton motive force (Δp), protons flow downhill across the membrane. This proton translocation makes the central stalk, which connects FO to F1, rotate counterclockwise (viewed from F1). Such rotation is promptly transmitted to the catalytic sector F1 that undergoes conformational changes which allow the synthesis of ATP from ADP and Pi. Basically, the whole enzyme machinery is based on a chemomechanical coupling which implies a Δp-driven rotation of the molecular motor FO at about 130 Hz (Nicholls and Ferguson 2013). Conversely, if the membrane is not enough energized, in other words if Δp is poor, the same F1FO complex acts as ATPase, namely it hydrolyzes ATP to ADP and Pi. In this case, the energy obtained from ATP hydrolysis is exploited to move protons uphill across the membrane through a clockwise rotation (viewed from F1) of FO, leading to Δp re-building (Dimroth et al. 2006). The thermodynamic equilibrium between the phosphorylation potential (ΔG p) of ADP and Δp determines which of the two opposite processes of synthesis/hydrolysis of ATP occurs. In other words, if Δp prevails on ΔG p, ATP is synthesized and if ΔG p prevails, ATP is hydrolyzed. The mechanism of proton translocation within FO is not yet fully understood. The fundamental constituents of the torque generation are the a subunit and the c-ring. The nature of a subunit is still partially obscure and controversial. Within a subunit, two aqueous ion semi-channels (Steed and Fillingame 2008) span across the membrane from the matrix to the intermembrane space. Unexpectedly, recent advances suggest that the semi-channel on the matrix side has horizontal helices, while the semi-channel at the luminal side would be vertical (Allegretti et al. 2015), namely in the same direction as proton flux. A quite complicated mechanism has been depicted (Elston et al. 1998; Stock et al. 1999), somehow based on the asymmetry of the two aqueous semi-channels within a subunit (Nesci et al. 2015) and on the properties of the so-called c-ring, a membrane-embedded cylindrical rotor which allows the flux of protons across the membrane and is the master player in both ATP synthesis and hydrolysis (Nicholls and Ferguson 2013).
The size and the constitution of the c-ring, conserved in the same species and apparently linked to the species bioenergetic requirement (von Ballmoos et al. 2008; Nesci et al. 2013a), determine the number of protons translocated by a complete (360°) rotation of the rotor to synthesize ATP and impose the bioenergetic cost of ATP to the species (Watt et al. 2010). The c-ring’s role in the bioenergetic cost of ATP is universal, being the Δp-driven rotary mechanism of the FO rotor shared by prokaryotes and eukaryotes.
Recent advances also unravel the involvement of the F1FO complex, and especially of the c-ring, in cell death. Accordingly, due to the enzyme capability of switching the energy transduction system from the energy-saving to the energy-dissipating mode, the F1FO-ATPase has been involved in the crucial event of the mitochondrial permeability transition (MPT), which triggers cell death (Bernardi et al. 2015). In turn, MPT has been related to the opening of the mitochondrial permeability transition pore (MPTP) in which the c-ring has been hypothetically involved. Once identified, the molecular components of MPTP can be exploited as strategic targets to treat pathologies related to MPT such as neurodegenerative disorders, cardiovascular diseases, and cancer (Bernardi and Di Lisa 2015; Bonora et al. 2015). Consistently, the F1FO complex, and specifically the c-ring, raises increasing interest in pharmacology (Sakthivel 2012).
Thus, in recent years, “the ATP synthase—a splendid molecular machine” (Boyer 1997), extensively studied in past decades for its key energy-saving role, turns out as an amazing multi-tasking enzyme. Its roles span from life to death with increasing corollary implications not only in the so-called mitochondrial diseases, but also, quite unexpectedly, in a wide variety of common pathologies. Among the enzyme constituents, the membrane-embedded c-ring emerges not only as a crucial structure in both catalytic functions of the enzyme, but also as one of the preferred sites of action of modulators and modifiers.
ATP Cost and c-Ring Size: The Structural Basis of Bioenergetics
The c-ring is the essential component of the FO rotor. In all organisms, it is constituted by monomers (c subunits) arranged in a circle as a cylindrical palisade which form and contain an internal phospholipid-containing hydrophobic cavity (Oberfeld et al. 2006). As far as we are aware, this universal c-ring constitution has few exceptions, as we will see later. Each hydrophobic hairpin-shaped c subunit constitutes the basic unit of the ring: the N- and C-terminal α-helices of each subunit flank the same terminal regions of another subunit thus forming two concentric circles. In eukaryotes, these two circles in each c subunit are linked by a loop region which faces the head-group region of phospholipids on the matrix side of the inner mitochondrial membrane (Walker 2013). The c-ring is directly involved in the proton translocation across the membrane which is based on its structural properties. According to the depicted molecular model, the protons to be translocated flow within the semi-channel facing the positive side of the bilayer and protonate a carboxyl group, Asp or Glu depending on the species, at approximately half of the transmembrane C-terminal α-helix of a c subunit. The protonated carboxyl group switches from the open conformation to the locked conformation, which is energetically favored to penetrate into the membrane during the c-ring rotation. In this way, the protonated c subunit, namely in its neutral form, reaches the semi-channel of the a subunit facing the negative membrane side. Then the carboxylic group returns to the open conformation being its deprotonation favored by the basic environment (Pogoryelov et al. 2009, 2010; Symersky et al. 2012a).
Interestingly, the c-ring stoichiometry is constant in a given species, but the number of c subunits can be in the range 8–15 and consequently the c-ring size differs among species (von Ballmoos et al. 2009) (Fig. 1). Eukaryotic ATP synthases have small c-rings, while prokaryotic and chloroplast enzymes usually contain large c-rings, with up to 15 subunits in cyanobacteria (Pogoryelov et al. 2005). Probably, the different size of the c-ring may result from evolutionary adaptation to the various environmental or cellular conditions of ATP production (von Ballmoos et al. 2008). In eukaryotes, the inner helix of each c subunit accommodates the highly conserved motif of four glycine residues (G × G × G × G), which confers tight transmembrane α-helix packing, without space for side chains (Vonck et al. 2002). Interestingly, under conditions of low overall Δp in alkaline environment (e.g., in the extreme alkaliphilic Bacillus pseudofirmus OF4), the G × G × G × G motif is replaced by A × A × A × A, namely the methyl side chain of alanine replaces the hydrogen of glycine. This amino acid substitution enhances both the c-ring stoichiometry and its size by stretching the encoded amino acid sequence at the N-terminal helix (Preiss et al. 2013). In most cases, according to the mechanism of proton transport depicted above, the number of c subunits is tightly linked to the number of transported protons. However any rule can have exceptions. The F/V-hybrid rotor ring, which from an evolutionary standpoint lies between the ATP synthase and H+ pumps, is a good example of a condition in which the number of ion-binding sites which establishes the number of transported protons does not correspond to the number of c-ring subunits. In Acetobacterium woodii, the heteromeric architecture of the c-ring (9:1 of F- and V-type c subunits, respectively) contains single-hairpin c subunits which host one ion-binding site and a double-hairpin c subunit with one additional site and one vacancy which does not bind ions (Matthies et al. 2014). Apparently, during evolution, living organisms have adapted the c-ring size to work optimally under the conditions dictated by the prevailing electrochemical parameter (Nesci et al. 2013a). Accordingly, ∆p consists of two components: the electric gradient, namely the transmembrane membrane electric potential (∆φ), and the chemical gradient, namely the difference in proton concentrations between the two sides of the membrane (∆pH).
When ∆φ is the dominant driving force (e.g., in mitochondria), the c-ring is small. Conversely, in chloroplasts, where a large ∆pH is accompanied by a small ∆φ, the F1FO-ATPase has a large c-ring (e.g., formed by 14 subunits, as shown in Fig. 1) to compensate for the low ∆φ (von Ballmoos et al. 2008). This functional adaptation is somehow explained by a mechanical analogy on considering how the gear on the back wheel of a bicycle works (Nicholls and Ferguson 2013). A small gear requires a lot of force, but few rides, to make the back wheel rotate. Thus, the rotation of the small mitochondrial c-ring requires the translocation of a less number of protons across the membrane, being proton flux driven by the high ∆φ. On the other hand, large c-rings can rotate in the presence of low ∆φ and high ∆pH by translocating a high number of protons (von Ballmoos et al. 2008; Nesci et al. 2015).
The rotation angle of the rotor is inversely proportional to the number of c subunits (n). Indeed, in a complete rotation of the rotor (360°), a low n value (i.e., small c-ring) implies a higher rotation angle, for each c subunit, than a high n value (i.e., large c-ring). The translocation of the same number of protons by differently sized c-rings can be only obtained if small c-rings perform more revolutions than large c-rings. In other words, since each 360° rotation means three synthesized ATPs, from a bioenergetic standpoint small c-rings have higher return than large c-rings, since they produce more ATP molecules for a stated number of translocated protons. In general, since each FO-c subunit possesses a protonation site, during a 360° rotation of the rotor the protons are translocated across the membrane. At the same time, since the F1 sector has three substrate-binding sites (one on each β-subunit) (Boyer 1997), the synthesis or the hydrolysis of 3 ATP molecules occurs, according to the direction of rotation of the rotor. The thermodynamic parameter H+/ATP ratio (i) defines the energy cost of ATP synthesis by the F1FO-ATPase. Accordingly, the stoichiometric ratio of c subunits to β-subunits also coincides with i in F-type ATPase (Petersen et al. 2012). The bioenergetic cost of ATP is linked to the number of ATP molecules synthesized for each electron pair transferred from a defined substrate (NADH or succinate) via the respiratory complexes to oxygen (Ferguson 2010). The relationship between phosphorylation and respiration/oxidation is simplified by the P/O ratio or P/2e – ratio. The consensus values for the number of protons pumped out in the intermembrane space per electron pair transferred to O2 (H+/O) are 10 protons for NADH and 6 protons for succinate as substrates, and these values are constant. Therefore, the number of synthesized ATP molecules for each oxidized substrate can be calculated from the ratio of respiration stoichiometry (H+/O) to i. However, the transmembrane transport of ADP and phosphate (Pi), required to form ATP, namely the electrogenic \({\text{ATP}}_{{({\text{out}})}}^{ 4- } /{\text{ADP}}_{{({\text{in}})}}^{ 3- }\) antiport by the adenine nucleotide translocator (ANT) and the electroneutral H2PO4−/H+ symporter or H2PO4−/OH− antiporter by the phosphate carrier (PiC), should be considered. Therefore, the denominator of the fraction which defines the P/O ratio is i + 1:
Even if the P/O ratio is a mechanistic constant for any particular substrate (Brand and Nicholls 2011), it depends on the c-ring size, which is directly linked to i. Accordingly, at constant H+/O ratio, a small c-ring builds more ATP molecules than a large c-ring (Silverstein 2014), since the low n value linked to i decreases the denominator of the fraction and increases the P/O ratio.
The ∆G p and ∆p values for the F1FO-ATP synthase are mutually related by the thermodynamic relationship:
in which i is a variable and F is the Faraday constant. At fixed ∆G p, ∆p and (i + 1) are inversely proportional. As a corollary, in mammalian mitochondria to generate a given ΔG p in the presence of higher Δp, a lower value of i is required with respect to other organisms (Nicholls and Ferguson 2013). This condition should be fulfilled to yield ATP synthesis, since the F1FO-ATPase switches between the two opposite modes of ATP hydrolysis/synthesis according to the reversal potential threshold (E rev), which in turn is inversely proportional. In other words, E rev increases as i decreases. This implies that in mitochondria the F1FO-ATPase is especially sensitive to a potential drop, namely a slight membrane depolarization will trigger the transition from ATP synthesis to ATP hydrolysis (Nesci et al. 2015). To sum up, a small c-ring requires only few protons to produce a single molecule of ATP but, as a consequence, it requires high ∆p to allow ATP synthesis.
Therefore, the bioenergetic cost of ATP, the energy currency of the cell, is related in a very simple way with the c-ring stoichiometry, which finely tunes the thermodynamic parameters of oxidative phosphorylation.
The c-Ring and the Mystery of MPT
Recent advances increasingly hint that the ATP synthase, and especially the c-ring, may constitute or contribute to the formation of the mysterious MPTP, a proteinaceous pore in the inner mitochondrial membrane, whose molecular architecture is still an enigma. In turn, MPTP is the key element of the MPT, the so-called mitochondrial permeability transition, first discovered in 1970s (Hunter and Haworth 1979), which dramatically changes the permeability features of the mitochondrial membrane. Alterations in the mitochondrial inner membrane permeability to ions and solutes, with molecular masses up to approximately 1.5 kDa, lead to matrix swelling. The MTP, which could be due to the reversible opening of the MPTP, commits cells to suicide via regulated necrosis or apoptosis (Bernardi et al. 2006). The MPT is triggered by high Ca2+ concentrations in mitochondria, stimulated by Pi and certain fatty acids, sensitized by oxidative stress, and conversely inhibited by Mg2+ and ADP (Lehninger 1959; Azzone and Azzi 1965a, b). A crucial role in MPT modulation was assigned to cyclosporine A (CsA), in turn pharmacological target of cyclophilin D (CyP-D), also known to be relevant in MPTP regulation (Crompton et al. 1988).
In search for the structural bases of MPTP, several models have been hypothesized. According to a first model, never experimentally confirmed, the outer and inner mitochondrial membranes would generate a contiguous pore constituted by the voltage-dependent anion channel (VDAC) embedded in the outer mitochondrial membrane (Baines et al. 2007) and by the ANT in the inner mitochondrial membrane (Kokoszka et al. 2004). On the other hand, recent evidence suggests that the two outer and inner mitochondrial membranes work separately to open the MPTP. The Bcl-2 protein family members Bax and Bak would facilitate the permeability of the outer membrane involved in MPTP (Karch et al. 2013), while the inner component, whose molecular entity remains up to now elusive, would constitute the regulatory site. After about 60 years of studies on the nature of the inner pore-forming membrane, the MPTP was found to generate currents with indistinguishable features from those produced by the Ca2+-dependent F1FO-ATPase dimers (Antoniel et al. 2014). The H+-pumping activity of F1FO-ATPases could be different if Ca2+ or Mg2+ acts as a cofactor. Indeed, ATP hydrolysis stimulated by Ca2+ was uncoupled to proton pumping in beef heart submitochondrial particles (Papageorgiou et al. 1998); similarly Ca2+-dependent F1FO activities uncoupled to proton pumping were detected in Rhodospirillum rubrum (Nathanson and Gromet-Elhanan 2000). Perhaps, the different ligand (Ca2+ or Mg2+) may promote a different conformational state of the catalytic site. Changes in the interactions between the β and γ subunits of F1 are known to be required to link catalysis to proton translocation through FO (Nathanson and Gromet-Elhanan 2000). This link (namely the coupling) is known to be signaled by the ATPase sensitivity to the specific inhibitor oligomycin (Runswick et al. 2013). Reconstituted mitochondrial F1FO-ATPase dimers treated with Ca2+ create a MPTP-like activated channel. In this structure, CyP-D in the presence of Pi inhibits the F1FO-ATP synthase activity by binding to the OSCP subunit (Giorgio et al. 2009), while CsA removes CyP-D and reactivates the enzyme. Interestingly, in recent years a prominent role of the F1FO-ATPase c-ring in MPTP constitution is emerging (Bonora et al. 2015) since agents targeting or gene-silencing the c subunits protect against MPTP opening (Bonora et al. 2013). Moreover, the phosphorylation status of c subunits might modulate the MPTP kinetics and cation selectivity (Azarashvili et al. 2014). Consistently, the c-ring was shown to generate a non-specific current ascribable to the MPTP (Alavian et al. 2014). However, the newly proposed mechanisms involving the c subunits reconstituted in membranes in the formation of a pore refractory to CyP-D are still unclear. Assumed that MPTP opening caused by Ca2+ overload in mitochondria would detach the c-ring from F1, CsA and other MPTP inhibitors would prevent this decoupling (Alavian et al. 2014). However, the intriguing putative role of the c-ring in MPTP has not been confirmed yet. The findings up to now reported on this topic appear in some cases contradictory and do not justify the MPTP regulation by its effectors. The finding of Bernardi’s group that only purified F1FO-ATPase dimers, and not monomers, have MPTP-like channel activity (Giorgio et al. 2013), once confirmed, will open new frontiers in the identification of the F1FO-ATPase portion involved in MPTP formation. However, the known features of the inhibitory factor 1 (IF1), which promotes F1FO-ATPase dimerization, supports cristae structure, preserves the mitochondrial morphology and ultrastructure, protects against the apoptotic/necrotic death linked to the ATPase inhibition (Faccenda et al. 2013), and apparently weakens the putative involvement of ATP synthase dimers in MPTP formation.
Other findings support the hypothesis that the c-ring may associate with other membrane proteins such as ANT and PiC, at first considered as MPTP components, to form the ATP synthasome complex (Chen et al. 2004). In such complex, ANT and PiC could modulate the pore-forming capability of the c-ring (Halestrap 2014).
To sum up, the whole matter is still controversial, and up to now contradictory evidence cannot lead to define which component of the ATP synthase is involved in the MPTP. Indeed, if the putative F1FO-ATPase role in the mysterious MPTP constitution will be confirmed, the F1FO complex, and especially its master player c-ring, will emerge as a prominent multi-subunit protein of both life and death.
The Common Drug-Binding Site on the c-Ring and the Modulation of Drug Sensitivity
Apart from the presumptive involvement of the c-ring in MPTP, the F1FO complex is increasingly believed as a molecular switch between life and death. Accordingly, the assertion “no ATP synthase no life” is much more than a slogan (Nesci et al. 2014a). Due to its double-faced role, the enzyme complex can be effectively exploited to regulate energy metabolism and selectively fate cells to death. Thus, it emerges as an ideal molecular target for drugs (Sakthivel 2012). Among the wealth and wide variety of F1FO-ATPase inhibitors, most compounds were initially shown to act on the catalytic activity of the hydrophilic domain of F1, the much more studied sector. Interestingly, other compounds do not affect F1, at least at low concentrations, and prevent the proton translocation through the embedded FO domain (Hong and Pedersen 2008) by specifically binding to c subunits. Often these compounds, due to this molecular mechanism, block both enzyme functions, namely ATP synthesis and ATP hydrolysis. Additionally, the c-ring was shown to embrace a common drug-binding region in which different compounds can also localize simultaneously by selectively interacting with their specific binding sites and display different inhibitory potency (Nesci et al. 2014c).
The amino acid sequences of c subunits are identical for almost all vertebrates and highly conserved in invertebrates (Watt et al. 2010). However, they significantly vary between eukaryotes and prokaryotes and even among different bacterial species. Since the structure and functionality of the c subunits in F1FO-ATPase are universal, the identification and isolation of drugs selectively acting on the bacterial enzyme is a crucial challenge. Accordingly, renewed hope for innovative therapies against recalcitrant diseases sustained by bacteria might stem from the exploitation of slight differences between eukaryotic and prokaryotic proteins which can serve as molecular tools to selectively manipulate the F1FO-ATP synthase function. Differently from other bacteria, mycobacteria entirely rely on the ATP synthase for optimal growth (Singh et al. 2013). Diarylquinolines, which target F1FO-ATPase c subunits of Mycobacterium tuberculosis (Koul et al. 2007), are an emerging class of antimycobacterial drugs under clinical trials. Among them, bedaquiline, also known as TMC207 or R207910, has high selectivity for the mycobacterial enzyme, which displays a more than 20,000-fold higher affinity for the drug than the mitochondrial F1FO-ATPase (Haagsma et al. 2009). This property minimizes or even rules out any concern of possible toxic side effects on the host eukaryotic enzyme and encourages its clinical use. The drug efficiently inhibits the proton translocation by binding to the c-ring of mycobacteria (Preiss et al. 2015), favored by the appropriate amino acid sequence of c subunits of M. tuberculosis. Bedaquiline acts on all life stages of the microorganism (Lakshamanan and Xavier 2013), probably because the species-specific c-ring composition is maintained. Indeed, the crystal structure of c 9-ring from nonpathogenic M. phley shares a tight sequence identity with M. tuberculosis, especially in the transmembrane portion of c subunits which binds bedaquiline (Andries et al. 2005; Haagsma et al. 2009). The H+-binding site, in each c subunit, is provided by glutamate (E61) on the C-terminal α-helix. The oxygen atoms of E61 carboxyl group are engaged in a hydrogen bond network with D28 on the N-terminus of the same α-helix, which stabilizes the glutamate conformation. A second bond formed with one water molecule coordinates the oxygen of backbone carbonyl of L59 on the C-terminus of the adjacent monomer. In detail, the amino acid side chains of the ion coordination region, as well as I66 from the adjacent C-terminal α-helix, define a cleft motif between two c subunits which anchor the diarylquinoline molecule (Segala et al. 2012). The complex net built by the different interactions which tightly anchor bedaquiline to c subunits has been recently defined (Preiss et al. 2015) (Fig. 2). The overall interaction pattern is very similar in M. tuberculosis and M. phley, even if the position of the amino acid residues involved is slightly different in the two species, as detailed below. In both cases, a wide spectrum of interactions is established between bedaquiline and the surrounding amino acid residues of the C-terminal α-helices of two c subunits, i.e., the protomer cH, which contains the proton-binding site blocked by the drug, and the adjacent protomer cA. A close insight reveals an intriguing net of multiple interactions which are summarized as follows. The quinolone moiety of the drug binds to the residues G58 (G62 in M. phley), E61 (E65 in M. phley), A62 (A66 in M. phley), and F65 (F69 in M. phley) of cH. In addition, E61 (E65 in M. phley) of cH interacts through a specific hydrogen bond with the dimethylamino moiety of the drug which penetrates between the two adjacent monomers. Furthermore, bedaquiline through its hydroxyl group establishes water molecule bridges between the oxygen of backbone carbonyl and the carboxyl group of E61. The dimethylamino moiety of bedaquiline is also bound with Y64 (Y68 in M. phley) of cH, and with A62 (A66 in M. phley) and A63 (A67 in M. phley) of cA, while the naphthyl group establishes hydrophobic interactions among Y64 (Y68 in M. phley) and L68 (L72 in M. phley) of cH and I66 (I70 in M. phley) of cA. Finally, F65 (F69 in M. phley) of cH, as a result of a conformational change induced by binding to the quinolone moiety, creates van der Waals interactions with the bedaquiline phenyl group (Preiss et al. 2015) (Fig. 2). The variety and the abundance of specific molecular interactions, which cannot be established in other prokaryotes and in eukaryotes, concur to determine the high affinity of the mycobacterial c-ring for bedaquiline. Moreover, the proton barrier of the guanidinium group of arginine (R) of the a subunit (Mitome et al. 2010) acts on the ion-binding site during the putative intermediate rotation states of the c-ring (Pogoryelov et al. 2009). The arginine interaction is somehow mimicked by the intermolecular bond between E61 and dimethylamino moiety of bedaquiline in the membrane surrounding the c-ring. This bond would act as a trap in H+ transport mechanism of FO. Accordingly, the drug bound to the c-ring cannot attain the tight polar a/c interface of the F1FO-ATPase. According to Meier’s group (Preiss et al. 2015), only a single molecule of bedaquiline completely blocks the F1FO-ATPase torque generation. Therefore, any substitution in the amino acid which defines the cleft motif between two adjacent c subunits will produce bedaquiline-resistant mutants of M. tuberculosis (Segala et al. 2012).
If up to now the genus Mycobacterium emerges as the only suitable target of bedaquiline, in recent years novel diarylquinolines, differing from bedaquiline in the side chains and also targeting bacterial c subunits, emerged as promising drugs to fight resistant strains of Gram-positive bacteria, including Staphylococcus aureus and Streptococcus pneumoniae (Balemans et al. 2012). It seems likely that the antibacterial spectrum of diarylquinolines can be even broadened, maintaining the same molecular target, by providing slight changes in their molecular structure (Singh et al. 2014) to optimize their selective binding to the c-ring.
The interaction of macrolide antibiotics with FO and specifically with the c-ring are an emerging field of study. Oligomycin, a specific inhibitor of transmembrane FO domain (which takes the O subscript from oligomycin), as well as other macrolide antibiotics, inhibits the H+ translocation required for the torque generation, in turn essential for the F1FO-ATPase machinery (Nesci et al. 2014b). Oligomycin belongs to the polyketide class of macrolide antibiotics whose basic structure consists of polymers of ketide units arranged to build a large lactone ring covalently bound to one or more deoxy sugars. The macrolide ring confers the inhibition power, while the deoxy sugar moiety is not crucial for the ATPase inhibition (Salomon et al. 2001). The oligomycin-binding site on the c subunits has been defined at high-resolution (1.9 Å) crystal structure (Symersky et al. 2012b). Interestingly, macrolide drugs featured by different polyketide backbones display a similar inhibition mechanism but a different inhibition potency. Oligomycin binds to the amino acid side chains of two adjacent c subunits of FO, c1 and c2, and covers the H+-binding site (E59) on c1. By shielding the carboxyl access to the aqueous environment of the proton half channel of a subunit, oligomycin blocks the proton flux within FO without affecting the c-ring backbone conformation (Symersky et al. 2012b). On the contrary, on the C-terminal α-helices the side chains of L63 of c1 subunit and F64 of c2 subunit would rotate to allow the propanol residue linked to the spiropyranose sugar rings of oligomycin to penetrate between the two c monomers so as to establish non-covalent interactions with the α-helical N-terminus of the c1 subunit. The macrocyclic lactone ring is involved in both hydrophilic and hydrophobic interactions with 7 amino acids of the C-terminal α-helices of c1 subunit and 5 amino acids of the C-terminal α-helix of c2 subunit. The proton-binding site (E59 of c1 subunit) is also involved in oligomycin binding via a bridging water molecule (Symersky et al. 2012b). Multiple inhibition analysis of the F1FO-ATPase carried out with different macrolides slightly differing in the polyketide ring pointed out that each compound requires a different amino acid combination to bind to the c-ring (Nesci et al. 2014c). Therefore, the decrease in the mitochondrial ATPase sensitivity to macrolides produced by post-translation modification (Pagliarani et al. 2013) and the multiple drug resistance induced by amino acid mutations (Galanis et al. 1989; Nagley et al. 1986) are consistent in strongly suggesting that macrolide antibiotics share a common binding region within FO in which each compound specifically binds to its specific site (Nesci et al. 2014c).
All mitochondrial c subunits have a conserved cysteine on the α-helix C-terminal. Interestingly, post-translational modifications at this conserved cysteine can substantially modify the common drug-binding site. The same sensitivity loss to oligomycin induced by thiol oxidation was found in different animal phyla (Nesci et al. 2011, 2014b). The F1FO-ATPase desensitization to oligomycin can be extended to all inhibitors which share the binding region on the enzyme. In contrast, the c subunits of prokaryotic ATP synthases lack cysteine on the external transmembrane α-helix, and this crucial site is refractory to post-translational modifications involving cysteines (Nesci et al. 2014b). Indeed, in Saccharomyces cerevisiae strains, a single amino acid mutation (Cys65Ser) in the C-terminal α-helix of c subunit induces oligomycin resistance (Sebald et al. 1979). The mitochondrial F1FO-ATPase desensitization to macrolide drugs by tributyltin (TBT) is due to TBT binding to a low-affinity site on FO (Nesci et al. 2012), and this effect was not produced by other butyltins (Nesci et al. 2013b). Accordingly, when oligomycin blocks the rotation of the c-ring, TBT binding, by reversibly oxidizing critical thiols on the c-ring, may promote a conformational change in the oligomycin–enzyme complex, which in turn would destabilize the drug-binding site (Fig. 3) allowing proton translocation recovery (Nesci et al. 2014c). Therefore, the F1FO-ATPase susceptibility to macrolide antibiotics can be abolished in eukaryotes and maintained in bacteria, due to the different amino acid sequences of c subunits and particularly to the lack of the crucial cysteines in bacteria.
Thus, the structural features of the c-ring could per se allow the molecular switch off to drugs of the F1FO-ATPase. Differences in the amino acid sequence between eukaryotic and prokaryotic c subunits can be exploited to specifically inhibit proton translocation in one species without affecting that in another species (Nesci et al. 2014a). On the other hand, structural studies on post-translational modifications of F1FO-ATPase c subunits can elicit structure-related changes in the protein functionality which may be exploited in therapy. According to a fascinating perspective, the c-ring could be made insensitive to drugs in eukaryotes by post-translational modifications, while, at the same time, the different amino acid composition in the bacterial enzyme counterpart would make the c-ring refractory to these chemical modifications and preserve the sensitivity to the drug. Clearly, the ideal antimicrobic drug kills bacteria without eliciting significant side effects in the eukaryotic host. On these bases, the possible modulation of the c-ring structural properties opens intriguing perspectives in pharmacology and stimulates the development of new drugs targeting the ATP synthase and specifically the c-ring.
Conclusion
The c-ring of the F1FO-ATP synthase is the amazing demonstration of how a simple polymeric structure may sustain multiple key functions. Accordingly, the c-ring plays a crucial role in cellular bioenergetics as its constitution is somehow adaptive to the metabolic requirements of the species. The unique function of thermodynamic machine of the F1FO-ATPase in oxidative phosphorylation, which per se is extraordinary in biology, would be extended if the c-ring’s role in the MPT will be fully validated. In addition, the c-ring, as a target of different drugs, could enhance the therapeutic potential of the mitochondrial enzyme and open the door to new medical approaches.
To sum up, indeed we can say that the F1FO-ATP synthase is “the lord of the (c-)ring.”
References
Alavian KN, Beutner G, Lazrove E, Sacchetti S, Park HA, Licznerski P, Li H, Nabili P, Hockensmith K, Graham M, Porter GA Jr, Jonas EA (2014) An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci USA 111:10580–10585. doi:10.1073/pnas.1401591111
Allegretti M, Klusch N, Mills DJ, Vonck J, Kühlbrandt W, Davies KM (2015) Horizontal membrane-intrinsic α-helices in the stator a-subunit of an F-type ATP synthase. Nature 521:237–240. doi:10.1038/nature14185
Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V (2005) A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307:223–227
Antoniel M, Giorgio V, Fogolari F, Glick GD, Bernardi P, Lippe G (2014) The oligomycin-sensitivity conferring protein of mitochondrial ATP synthase: emerging new roles in mitochondrial pathophysiology. Int J Mol Sci 15:7513–7536. doi:10.3390/ijms15057513
Azarashvili T, Odinokova I, Bakunts A, Ternovsky V, Krestinina O, Tyynelä J, Saris NE (2014) Potential role of subunit c of F0F1-ATPase and subunit c of storage body in the mitochondrial permeability transition. Effect of the phosphorylation status of subunit c on pore opening. Cell Calcium 55:69–77. doi:10.1016/j.ceca.2013.12.002
Azzone GF, Azzi A (1965a) Volume changes in liver mitochondria. Proc Natl Acad Sci USA 53:1084–1089
Azzone GF, Azzi A (1965b) Volume changes induced by inorganic phosphate in liver mitochondria. Biochem J 94:10C–11C
Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD (2007) Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9:550–555
Balemans W, Vranckx L, Nounis N, Pop O, Guillermont J, Vergauwen K, Mol S, Glissen R, Motte M, Lancois D, De Bolle M, Bonroy K, Lill H, Andries K, Bald D, Koul A (2012) Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria. Antimicrob Agents Chemother 56:4131–4139
Bernardi P, Di Lisa F (2015) The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection. J Mol Cell Cardiol 78:100–106. doi:10.1016/j.yjmcc.2014.09.023
Bernardi P, Krauskopf A, Basso E, Petronilli V, Blachly-Dyson E, Di Lisa F, Forte MA (2006) The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 273:2077–2099
Bernardi P, Di Lisa F, Fogolari F, Lippe G (2015) From ATP to PTP and back: a dual function for the mitochondrial ATP synthase. Circ Res 116:1850–1862
Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S, Patergnani S, Rimessi A, Suski JM, Wojtala A, Wieckowski MR, Kroemer G, Galluzzi L, Pinton P (2013) Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12:674–683. doi:10.4161/cc.23599
Bonora M, Wieckowski MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P (2015) Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 34:1608. doi:10.1038/onc.2014.462
Boyer PD (1997) The ATP synthase—a splendid molecular machine. Annu Rev Biochem 66:717–749
Brand MD, Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435:297–312. doi:10.1042/BJ20110162
Chen C, Ko Y, Delannoy M, Ludtke SJ, Chiu W, Pedersen PL (2004) Mitochondrial ATP synthasome: three-dimensional structure by electron microscopy of the ATP synthase in complex formation with carriers for Pi and ADP/ATP. J Biol Chem 279:31761–31768
Crompton M, Ellinger H, Costi A (1988) Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 255:357–360
Dimroth P, von Ballmoos C, Meier T (2006) Catalytic and mechanical cycles in F-ATP synthases. EMBO Rep 7:276–282
Elston T, Wang H, Oster G (1998) Energy transduction in ATP synthase. Nature 391:510–513
Faccenda D, Tan CH, Seraphim A, Duchen MR, Campanella M (2013) IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling. Cell Death Differ 20:686–697. doi:10.1038/cdd.2012.163
Ferguson SJ (2010) ATP synthase: from sequence to ring size to the P/O ratio. Proc Natl Acad Sci USA 107:16755–16756. doi:10.1073/pnas.1012260107
Galanis M, Mattoon JR, Nagley P (1989) Amino acid substitutions in mitochondrial ATP synthase subunit 9 of Saccharomyces cerevisiae leading to venturicidin or ossamycin resistance. FEBS Lett 249:333–336
Giorgio V, Bisetto E, Soriano ME, Dabbeni-Sala F, Basso E, Petronilli V, Forte MA, Bernardi P, Lippe G (2009) Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 284:33982–33988. doi:10.1074/jbc.M109.020115
Giorgio V, von Stockum S, Antoniel M, Fabbro A, Fogolari F, Forte M, Glick GD, Petronilli V, Zoratti M, Szabó I, Lippe G, Bernardi P (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci USA 110:5887–5892. doi:10.1073/pnas.1217823110
Giraud MF, Paumard P, Sanchez C, Brèthes D, Velours J, Dautant A (2012) Rotor architecture in the yeast and bovine F1-c-ring complexes of F-ATP synthase. J Struct Biol 177:490–497. doi:10.1016/j.jsb.2011.10.015
Haagsma AC, Abdillahi-Ibrahim R, Wagner MJ, Krab K, Vergauwen K, Guillemont J, Andries K, Lill H, Koul A, Bald D (2009) Selectivity of TMC207 towards mycobacterial ATP synthase compared with that towards the eukaryotic homologue. Antimicrob Agents Chemother 53:1290–1292. doi:10.1128/AAC.01393-08
Halestrap AP (2014) The C ring of the F1Fo ATP synthase forms the mitochondrial permeability transition pore: a critical appraisal. Front Oncol. 4:234. doi:10.3389/fonc.2014.00234
Hong S, Pedersen PL (2008) ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas. Microbiol Mol Biol Rev 72:590–641. doi:10.1128/MMBR.00016-08
Hunter DR, Haworth RA (1979) The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195:453–459
Junge W, Müller DJ (2011) Biochemistry. Seeing a molecular motor at work. Science 333:704–705. doi:10.1126/science.1210238
Junge W, Sielaff H, Engelbrecht S (2009) Torque generation and elastic power transmission in the rotary F(O)F(1)-ATPase. Nature 459:364–370. doi:10.1038/nature08145
Karch J, Kwong JQ, Burr AR, Sargent MA, Elrod JW, Peixoto PM, Martinez-Caballero S, Osinska H, Cheng EH, Robbins J, Kinnally KW, Molkentin JD (2013) Bax and Bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. Elife 2:e00772. doi:10.7554/eLife.00772
Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, Wallace DC (2004) The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427:461–465
Koul A, Dendouga N, Vergauwen K, Molenberghs B, Vranckx L, Willebrords R, Ristic Z, Lill H, Dorange I, Guillemont J, Bald D, Andries K (2007) Diarylquinolines target subunit c of mycobacterial ATP synthase. Nat Chem Biol 3:323–324
Lakshamanan M, Xavier AS (2013) Bedaquiline-the first ATPsynthase inhibitor against multi-drug resistant tuberculosis. J Young Pharm 5:112–115. doi:10.1016/j.jyp.2013.12.002
Lehninger AL (1959) Reversal of various types of mitochondrial swelling by adenosine triphosphate. J Biol Chem 234:2465–2471
Matthies D, Zhou W, Klyszejko AL, Anselmi C, Yildiz Ö, Brandt K, Müller V, Faraldo-Gómez JD, Meier T (2014) High-resolution structure and mechanism of an F/V-hybrid rotor ring in a Na+-coupled ATP synthase. Nat Commun. doi:10.1038/ncomms6286
Meier T, Polzer P, Diederichs K, Welte W, Dimroth P (2005) Structure of the rotor ring of F-type Na+-ATPase from Ilyobacter tartaricus. Science 308:659–662
Mitome N, Ono S, Sato H, Suzuki T, Sone N, Yoshida M (2010) Essential arginine residue of the F(o)-a subunit in F(o)F(1)-ATP synthase has a role to prevent the proton shortcut without c-ring rotation in the F(o) proton channel. Biochem J 430:171–177. doi:10.1042/BJ20100621
Nagley P, Hall RM, Ooi BG (1986) Amino acid substitutions in mitochondrial ATPase subunit 9 of Saccharomyces cerevisiae leading to oligomycin or venturicidin resistance. FEBS Lett 195:159–163
Nathanson L, Gromet-Elhanan Z (2000) Mutations in the beta-subunit Thr(159) and Glu(184) of the Rhodospirillum rubrum F(0)F(1) ATP synthase reveal differences in ligands for the coupled Mg(2+)- and decoupled Ca(2+)-dependent F(0)F(1) activities. J Biol Chem 275:901–905
Nesci S, Ventrella V, Trombetti F, Pirini M, Pagliarani A (2011) Multi-site TBT binding skews the inhibition of oligomycin on the mitochondrial Mg-ATPase in Mytilus galloprovincialis. Biochimie 93:1157–1164. doi:10.1016/j.biochi.2011.04.008
Nesci S, Ventrella V, Trombetti F, Pirini M, Pagliarani A (2012) Tri-n-butyltin binding to a low-affinity site decreases the F1FO-ATPase sensitivity to oligomycin in mussel mitochondria. Appl Organomet Chem 26:593–599. doi:10.1002/aoc.2904
Nesci S, Ventrella V, Pagliarani A (2013a) Modulation of the F1FO-ATPase function by butyltin compounds. Appl Organomet Chem 27:199–205. doi:10.1002/aoc.2948
Nesci S, Ventrella V, Trombetti F, Pirini M, Pagliarani A (2013b) Mussel and mammalian ATP synthase share the same bioenergetic cost of ATP. J Bioenerg Biomembr 45:289–300. doi:10.1007/s10863-013-9504-1
Nesci S, Ventrella V, Trombetti F, Pirini M, Pagliarani A (2014a) Thiol oxidation of mitochondrial FO-c subunits: a way to switch off antimicrobial drug targets of the mitochondrial ATP synthase. Med Hypotheses 83:160–165. doi:10.1016/j.mehy.2014.05.004
Nesci S, Ventrella V, Trombetti F, Pirini M, Pagliarani A (2014b) The mitochondrial F1FO-ATPase desensitization to oligomycin by tributyltin is due to thiol oxidation. Biochimie 97:128–137. doi:10.1016/j.biochi.2013.10.002
Nesci S, Ventrella V, Trombetti F, Pirini M, Pagliarani A (2014c) Thiol oxidation is crucial in the desensitization of the mitochondrial F1FO-ATPase to oligomycin and other macrolide antibiotics. Biochim Biophys Acta 1840:1882–1891. doi:10.1016/j.bbagen.2014.01.008
Nesci S, Trombetti F, Ventrella V, Pagliarani A (2015) Opposite rotation directions in the synthesis and hydrolysis of ATP by the ATP synthase: hints from a subunit asymmetry. J Membr Biol 248:163–169. doi:10.1007/s00232-014-9760-y
Nicholls DG, Ferguson SJ (2013) Bioenergetics, 4th edn. Academic Press, Amsterdam
Oberfeld B, Brunner J, Dimroth P (2006) Phospholipids occupy the internal lumen of the c ring of the ATP synthase of Escherichia coli. Biochemistry 45:1841–1851
Pagliarani A, Nesci S, Ventrella V (2013) Modifiers of the oligomycin sensitivity of the mitochondrial F1FO-ATPase. Mitochondrion 13:312–319. doi:10.1016/j.mito.2013.04.005
Papageorgiou S, Melandri AB, Solaini G (1998) Relevance of divalent cations to ATP-driven proton pumping in beef heart mitochondrial F0F1-ATPase. J Bioenerg Biomembr 30:533–541
Petersen J, Förster K, Turina P, Gräber P (2012) Comparison of the H+/ATP ratios of the H+-ATP synthases from yeast and from chloroplast. Proc Natl Acad Sci USA 109:11150–11155. doi:10.1073/pnas.1202799109
Pogoryelov D, Yu J, Meier T, Vonck J, Dimroth P, Müller DJ (2005) The c15 ring of the Spirulina platensis F-ATP synthase: F1/Fo symmetry mismatch is not obligatory. EMBO Rep 6:1040–1044
Pogoryelov D, Yildiz O, Faraldo-Gómez JD, Meier T (2009) High-resolution structure of the rotor ring of a proton-dependent ATP synthase. Nat Struct Mol Biol 16:1068–1073. doi:10.1038/nsmb.1678
Pogoryelov D, Krah A, Langer JD, Yildiz Ö, Faraldo-Gómez JD, Meier T (2010) Microscopic rotary mechanism of ion translocation in the F(o) complex of ATP synthases. Nat Chem Biol 6:891–899
Preiss L, Yildiz O, Hicks DB, Krulwich TA, Meier T (2010) A new type of proton coordination in an F(1)F(o)-ATP synthase rotor ring. PLoS Biol 8:e1000443. doi:10.1371/journal.pbio.1000443
Preiss L, Klyszejko AL, Hicks DB, Liu J, Fackelmayer OJ, Yildiz Ö, Krulwich TA, Meier T (2013) The c-ring stoichiometry of ATP synthase is adapted to cell physiological requirements of alkaliphilic Bacillus pseudofirmus OF4. Proc Natl Acad Sci USA 110:7874–7879. doi:10.1073/pnas.1303333110
Preiss L, Langer JD, Yildiz Ö, Eckhardt-Strelau L, Guillemont JEG, Koul A, Meier T (2015) Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline. Sci Adv. doi:10.1126/sciadv.1500106
Runswick MJ, Bason JV, Montgomery MG, Robinson GC, Fearnley IM, Walker JE (2013) The affinity purification and characterization of ATP synthase complexes from mitochondria. Open Biol 3:120160. doi:10.1098/rsob.120160
Sakthivel S (2012) ATP-ase as a potential drug target for cancer, tumor growth and cellular functions. Int J Hum Genet 12:151–156
Salomon AR, Zhang Y, Seto H, Khosla C (2001) Structure-activity relationships within a family of selectively cytotoxic macrolide natural products. Org Lett 3:57–59
Sebald W, Wachter E, Tzagoloff A (1979) Identification of amino acid substitutions in the dicyclohexylcarbodiimide-binding subunit of the mitochondrial ATPase complex from oligomycin-resistant mutants of Saccharomyces cerevisiae. Eur J Biochem 100:599–607
Segala E, Sougakoff W, Nevejans-Chauffour A, Jarlier V, Petrella S (2012) New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure. Antimicrob Agents Chemother 56:2326–2334. doi:10.1128/AAC.06154-11
Silverstein TP (2014) An exploration of how the thermodynamic efficiency of bioenergetic membrane systems varies with c-subunit stoichiometry of F1FO ATP synthases. J Bioenerg Biomembr 46:229–241. doi:10.1007/s10863-014-9547-y
Singh H, Watt NK, Garewal N, Pugarzenthan T (2013) Bedaquiline: a new weapon against MDR and XDR-TB. Int J Basic Clin Pharmacol 2:96–102. doi:10.5455/2319-2003.ijbcp20130301
Singh S, Kaur G, Mangia V, Gupta MK (2014) Quinoline and quinolones: promising scaffolds for future antimycobacterial agents. J Enzyme Inhib Med Chem. doi:10.3109/14756366.2014.930454
Steed PR, Fillingame RH (2008) Subunit a facilitates aqueous access to a membrane-embedded region of subunit c in Escherichia coli F1F0 ATP synthase. J Biol Chem 283:12365–12372
Stock D, Leslie AG, Walker JE (1999) Molecular architecture of the rotary motor in ATP synthase. Science 286:1700–1705
Symersky J, Osowski D, Walters DE, Mueller DM (2012a) Oligomycin frames a common drug-binding site in the ATP synthase. Proc Natl Acad Sci USA 109:13961–13965. doi:10.1073/pnas.1207912109
Symersky J, Pagadala V, Osowski D, Krah A, Meier T, Faraldo-Gómez JD, Mueller DM (2012b) Structure of the c(10) ring of the yeast mitochondrial ATP synthase in the open conformation. Nat Struct Mol Biol 19(485–91):S1
Vollmar M, Schlieper D, Winn M, Büchner C, Groth G (2009) Structure of the c14 rotor ring of the proton translocating chloroplast ATP synthase. J Biol Chem 284:18228–18235. doi:10.1074/jbc.M109.006916
von Ballmoos C, Cook GM, Dimroth P (2008) Unique rotary ATP synthase and its biological diversity. Annu Rev Biophys 37:43–64. doi:10.1146/annurev.biophys.37.032807.130018
von Ballmoos C, Wiedenmann A, Dimroth P (2009) Essentials for ATP synthesis by F1FO ATP synthases. Annu Rev Biochem 78:649–672. doi:10.1146/annurev.biochem.78.081307
Vonck J, von Nidda TK, Meier T, Matthey U, Mills DJ, Kühlbrandt W, Dimroth P (2002) Molecular architecture of the undecameric rotor of a bacterial Na+-ATP synthase. J Mol Biol 321:307–316
Walker JE (2013) The ATP synthase: the understood, the uncertain and the unknown. Biochem Soc Trans 41:1–16. doi:10.1042/BST20110773
Watt IN, Montgomery MG, Runswick MJ, Leslie AG, Walker JE (2010) Bioenergetic cost of making an adenosine triphosphate molecule in animal mitochondria. Proc Natl Acad Sci USA 107:16823–16827. doi:10.1073/pnas.1011099107
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nesci, S., Trombetti, F., Ventrella, V. et al. The c-Ring of the F1FO-ATP Synthase: Facts and Perspectives. J Membrane Biol 249, 11–21 (2016). https://doi.org/10.1007/s00232-015-9860-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-015-9860-3